MedGenomics

MedGenome is a private genomics and precision medicine company focused on genetic diagnostics, multiomics research services, and bioinformatics-enabled healthcare applications. The company operates a large CAP-accredited genetic testing and multiomics laboratory in India and offers more than 1,300 diagnostic tests across areas including rare disease, oncology, reproductive health, infectious disease, and wellness. In addition to clinical diagnostics, MedGenome provides sequencing, bioinformatics, and multiomics services to academic, biotech, and pharmaceutical partners for biomarker discovery, translational research, and drug development. Its U.S. research services business was rebranded as Signios Bio in 2025, while the MedGenome brand remains centered on diagnostics and genomic medicine. The business is best characterized as a revenue-generating commercial genomics platform rather than a therapeutics developer with a classic drug pipeline.